Nadal, Aquilla Loraine A.

HRN: 24-78-72  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2025
MUPIROCIN 2%, 15G (TUBE)
04/28/2025
05/05/2025
TOPICAL
On Affected Lesions
TID
Cellulitis, Furuncle
Waiting Final Action 
04/28/2025
OXACILLIN 500MG (VIAL)
04/28/2025
05/05/2025
IV
525mg
Q6
Cellulitis
Waiting Final Action 
05/01/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/01/2025
05/07/2025
IVTT
105mg
Q6
T/C Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: